The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
The proceeds from the QIP will be utiized for purchase of outstanding optionally convertible debentures
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
Now approved for both acute and chronic HCV in adults and children aged 3 and above
Dilip Shanghvi to continue as the Executive Chairman of the Board
This strategic expansion marks a significant step in the company's global growth strategy
Subscribe To Our Newsletter & Stay Updated
